These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 6510256

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
    Maxwell DM, Brecht KM, Lenz DE, O'Neill BL.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):986-91. PubMed ID: 3418520
    [Abstract] [Full Text] [Related]

  • 3. Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions.
    Blick DW, Miller SA, Brown GC, Murphy MR.
    Pharmacol Biochem Behav; 1993 Jul; 45(3):677-83. PubMed ID: 8332626
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
    Solana RP, Gennings C, Carter WH, Anderson D, Lennox WJ, Carchman RA, Harris LW.
    Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality.
    Lennox WJ, Harris LW, Talbot BG, Anderson DR.
    Life Sci; 1985 Sep 02; 37(9):793-8. PubMed ID: 4033355
    [Abstract] [Full Text] [Related]

  • 9. A comparison of physostigmine and soman using taste aversion and nociception.
    Romano JA, King JM, Penetar DM.
    Neurobehav Toxicol Teratol; 1985 Sep 02; 7(3):243-9. PubMed ID: 4033865
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of subchronic pyridostigmine pretreatment on the toxicity of soman.
    Shiloff JD, Clement JG.
    Can J Physiol Pharmacol; 1986 Jul 02; 64(7):1047-9. PubMed ID: 3768795
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
    Lallement G, Foquin A, Dorandeu F, Baubichon D, Carpentier P.
    Drug Chem Toxicol; 2001 May 02; 24(2):165-80. PubMed ID: 11360433
    [Abstract] [Full Text] [Related]

  • 16. Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques.
    Hamilton LR, Schachter SC, Myers TM.
    Neurochem Res; 2017 Jul 02; 42(7):1962-1971. PubMed ID: 27900576
    [Abstract] [Full Text] [Related]

  • 17. Protection against both lethal and behavioral effects of soman.
    Harris LW, McDonough JH, Stitcher DL, Lennox WJ.
    Drug Chem Toxicol; 1984 Jul 02; 7(6):605-24. PubMed ID: 6534735
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pyridostigmine-induced decrement in skeletal muscle contracture is not augmented by soman.
    Anderson RJ, Chamberlain WL.
    Neurotoxicology; 1988 Jul 02; 9(1):89-96. PubMed ID: 3393305
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.